Komori
Terumo (4543) · InitiativeAchieved

Expanding stent graft design and branch-vessel capabilities through the acquisition of Aortica

First written in FY2020. 1 of 1 entries say "Achieved", first in FY2020. Latest entry: FY2020.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Expansion of the Surgical Business Product Portfolio and Use of External ResourcesA theme 4 companies write about · 0 as a headwind · 5 as a tailwind

0 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2020AchievedAnnual report

    「November 2019: Acquired Aortica Corp. in the United States.」

    Aortica Corp. develops, manufactures and sells case-planning software that automatically designs stent grafts and covered stents placed in small vessels branching from the aorta. The completion of the acquisition in November 2019 was initially recognized as an expansion of products and technologies in the cardiovascular business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Terumo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding stent graft design and branch-vessel capabilities through the acquisition of Aortica | TERUMO CORPORATION (4543) | Komori